# Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

> **NCT00380887** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 54 (—)

## Conditions studied

- Postmenopause

## Interventions

- **DRUG:** Premarin

## Key facts

- **NCT ID:** NCT00380887
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 54 (—)
- **Last updated:** 2006-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380887, "Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00380887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*